- Home
- KTCC vs CNTB Comparison
KTCC vs CNTB Comparison
Compare KTCC & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- CNTB
- Stock Information
- Founded
- KTCC 1969
- CNTB 2012
- Country
- KTCC United States
- CNTB United States
- Employees
- KTCC N/A
- CNTB N/A
- Industry
- KTCC Electrical Products
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- KTCC Technology
- CNTB Health Care
- Exchange
- KTCC Nasdaq
- CNTB Nasdaq
- Market Cap
- KTCC 63.6M
- CNTB 65.5M
- IPO Year
- KTCC N/A
- CNTB 2021
- Fundamental
- Price
- KTCC $5.79
- CNTB $1.11
- Analyst Decision
- KTCC
- CNTB Strong Buy
- Analyst Count
- KTCC 0
- CNTB 1
- Target Price
- KTCC N/A
- CNTB $8.00
- AVG Volume (30 Days)
- KTCC 25.3K
- CNTB 28.8K
- Earning Date
- KTCC 11-05-2024
- CNTB 09-05-2024
- Dividend Yield
- KTCC N/A
- CNTB N/A
- EPS Growth
- KTCC N/A
- CNTB N/A
- EPS
- KTCC N/A
- CNTB N/A
- Revenue
- KTCC $548,388,000.00
- CNTB $24,116,000.00
- Revenue This Year
- KTCC N/A
- CNTB N/A
- Revenue Next Year
- KTCC N/A
- CNTB $63.90
- P/E Ratio
- KTCC N/A
- CNTB N/A
- Revenue Growth
- KTCC N/A
- CNTB N/A
- 52 Week Low
- KTCC $3.60
- CNTB $0.68
- 52 Week High
- KTCC $6.14
- CNTB $2.84
- Technical
- Relative Strength Index (RSI)
- KTCC 48.70
- CNTB 45.31
- Support Level
- KTCC $5.60
- CNTB $0.98
- Resistance Level
- KTCC $6.11
- CNTB $1.09
- Average True Range (ATR)
- KTCC 0.21
- CNTB 0.10
- MACD
- KTCC -0.05
- CNTB -0.01
- Stochastic Oscillator
- KTCC 46.67
- CNTB 31.28
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.